Ive Grgas (left), team leader, Sunshine Act reporting/senior business analyst, Genentech, guided a panel on compliance training strategies, QC checks, and SOPs related to Sunshine Act implementation. Joining him on the panel, from left to right: Judy Johnson, CMP, president and chief executive officer, Rx Worldwide Meetings Inc.; Dawn DiPierro, senior manager, U.S. Compliance, Teva; and Gary Southard, director, faculty administration/transparency operations, Lilly USA, LLC.